SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
Sonoma Pharmaceuticals, Inc.
@SNOA_InsiderForm 4 Filing: Trombly Amy Moss Acquires (Grant) shares of $SNOA
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Sonoma Pharmaceuticals, Inc.
Ticker: $SNOA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-09
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Trombly Amy Moss, holds the title of Chief Executive Officer at Sonoma Pharmaceuticals, Inc..
On 2026-07-09, the insider transacted 10,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Trombly Amy Moss (Chief Executive Officer) was granted $0 of $SNOA
Post-Transaction Position: 52,185 shares
SEC Accession No: 0001683168-26-005422 (CIK: 1384640)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.